Published in J Diabetes Complications on June 14, 2016
Standards of medical care in diabetes--2014. Diabetes Care (2014) 20.97
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Adipose tissue, inflammation, and cardiovascular disease. Circ Res (2005) 8.72
Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med (2011) 7.42
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54
Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol (2009) 3.12
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2010) 2.22
Adiponectin actions in the cardiovascular system. Cardiovasc Res (2006) 1.92
Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes (2005) 1.87
Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes (2010) 1.80
Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care (2013) 1.62
Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care (2005) 1.59
Adiponectin: good, bad, or just plain ugly? Kidney Int (2008) 1.48
Editorial: Mortality and renal disease in type 1 diabetes mellitus--progress made, more to be done. J Clin Endocrinol Metab (2006) 1.29
Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.15
Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care (2013) 1.14
Adiponectin dysregulation and insulin resistance in type 1 diabetes. J Clin Endocrinol Metab (2012) 1.10
Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res (2007) 1.08
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care (2008) 1.04
Early diabetic nephropathy in type 1 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes (2014) 0.98
A practical method to measure GFR in people with type 1 diabetes. J Diabetes Complications (2014) 0.95
Urinary excretion of high molecular weight adiponectin is an independent predictor of decline of renal function in type 2 diabetes. Acta Diabetol (2013) 0.89
Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care (2008) 0.89
Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy. Diabetes Care (2015) 0.86
Insulin sensitivity and complications in type 1 diabetes: New insights. World J Diabetes (2015) 0.81
Adiponectin stimulates Rho-mediated actin cytoskeleton remodeling and glucose uptake via APPL1 in primary cardiomyocytes. Metabolism (2014) 0.80
Adiponectin-SOGA Dissociation in Type 1 Diabetes. J Clin Endocrinol Metab (2015) 0.79
Relationship of adiponectin and leptin with autoimmunity in children with new-onset type 1 diabetes: a pilot study. Pediatr Diabetes (2015) 0.78